• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜 D2 胃癌根治术的长期疗效:一项提出新假说的大型综合研究。

Long-Term Outcomes in Laparoscopic D2 Gastrectomy for Gastric Cancer: a Large Comprehensive Study Proposing Novel Hypotheses.

机构信息

Department of General Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China.

出版信息

J Gastrointest Surg. 2019 Jul;23(7):1349-1361. doi: 10.1007/s11605-018-4008-2. Epub 2018 Nov 26.

DOI:10.1007/s11605-018-4008-2
PMID:30478532
Abstract

BACKGROUND

The long-term outcomes of laparoscopic gastrectomy (LG) versus open gastrectomy (OG) for gastric cancer (GC) remain obscure, especially for advanced cancer and disease affecting the upper stomach and in older patients. This study aimed to comprehensively assess the long-term efficacy of LG for GC using a large prospective database.

METHODS

Totally, 1877 consecutive patients (1186 receiving LG and 691 OG) operated in 2004-2016 were analyzed, with a median follow-up of 63 months. Association of LG versus OG with disease-specific survival (DSS) and disease-free survival (DFS) overall and in various subgroups were investigated using multivariable Cox regression. Propensity score matching (PSM) was performed for sensitivity analysis.

RESULTS

Before PSM, overall, there was no significant association of LG versus OG with survival after multivariable adjustment; however, in subgroup analyses, LG was associated with superior DSS in patients aged ≥ 70 years and those with upper GC. No significant associations regarding DFS were observed overall or in stratifications. PSM analyses revealed that LG was associated with better DSS also in patients aged ≥ 70 years (hazard ratio (HR) = 0.33, 95% confidence interval (CI) = 0.15-0.72) and in those with upper GC (HR = 0.51, 95% CI = 0.29-0.91), and with better DFS in those with upper GC (HR = 0.60, 95% CI = 0.37-0.99). Multivariable analysis showed that age, hepatitis B, performance status, tumor histology, stage, and vascular invasion were significantly associated with post-LG survival. LG-specific nomograms were then constructed with concordance indexes of 0.814 (DSS) and 0.809 (DFS) and excellent calibration.

CONCLUSIONS

In this large institutional analysis, while LG for GC was associated with DSS and DFS similar to those for OG overall, non-inferior LG-associated survival especially DSS was observed in some subgroups rarely investigated in prospective or randomized settings. There could still be biases even after PSM due to confounders not accounted for in this observational study. However, these findings offer novel hypotheses for further validation.

摘要

背景

腹腔镜胃切除术(LG)与开腹胃切除术(OG)治疗胃癌(GC)的长期结果仍不清楚,尤其是对于晚期癌症和影响上胃的疾病以及老年患者。本研究旨在使用大型前瞻性数据库全面评估 LG 治疗 GC 的长期疗效。

方法

分析了 2004 年至 2016 年间接受手术的 1877 例连续患者(1186 例接受 LG,691 例接受 OG),中位随访时间为 63 个月。使用多变量 Cox 回归分析 LG 与 OG 与疾病特异性生存率(DSS)和无病生存率(DFS)的关系,以及在各种亚组中的关系。进行倾向评分匹配(PSM)以进行敏感性分析。

结果

在 PSM 之前,多变量调整后,LG 与 OG 与生存之间没有显著关联;然而,在亚组分析中,LG 与≥70 岁患者和上胃 GC 患者的 DSS 更高相关。在整体或分层中均未观察到与 DFS 相关的显著关联。PSM 分析显示,LG 与≥70 岁患者的 DSS 也更好相关(风险比(HR)=0.33,95%置信区间(CI)=0.15-0.72)和上胃 GC 患者(HR=0.51,95%CI=0.29-0.91),与上胃 GC 患者的 DFS 也更好相关(HR=0.60,95%CI=0.37-0.99)。多变量分析显示,年龄、乙型肝炎、表现状态、肿瘤组织学、分期和血管侵犯与 LG 后生存显著相关。然后构建了 LG 特异性列线图,其 DSS 的一致性指数为 0.814,DFS 的一致性指数为 0.809,且校准良好。

结论

在这项大型机构分析中,虽然 LG 治疗 GC 的 DSS 和 DFS 与 OG 相似,但在一些前瞻性或随机研究中很少研究的亚组中,LG 相关的非劣效生存,尤其是 DSS,观察到更好的生存。即使在 PSM 后,由于本观察性研究未考虑混杂因素,仍可能存在偏倚。然而,这些发现为进一步验证提供了新的假设。

相似文献

1
Long-Term Outcomes in Laparoscopic D2 Gastrectomy for Gastric Cancer: a Large Comprehensive Study Proposing Novel Hypotheses.腹腔镜 D2 胃癌根治术的长期疗效:一项提出新假说的大型综合研究。
J Gastrointest Surg. 2019 Jul;23(7):1349-1361. doi: 10.1007/s11605-018-4008-2. Epub 2018 Nov 26.
2
Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.腹腔镜与开腹胃癌根治术治疗临床及病理局部进展期胃癌的长期和短期疗效比较:倾向评分匹配分析。
Surg Endosc. 2018 Feb;32(2):735-742. doi: 10.1007/s00464-017-5730-7. Epub 2017 Jul 19.
3
Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.腹腔镜与开腹胃切除术治疗浆膜阳性(pT4a)胃癌的手术及长期肿瘤学结局:一项倾向评分匹配分析
Surg Oncol. 2019 Mar;28:167-173. doi: 10.1016/j.suronc.2019.01.003. Epub 2019 Jan 8.
4
Comparison of short-term and long-term efficacy of laparoscopic and open gastrectomy in high-risk patients with gastric cancer: a propensity score-matching analysis.腹腔镜与开腹胃癌根治术治疗高危胃癌患者的短期和长期疗效比较:倾向评分匹配分析。
Surg Endosc. 2019 Jan;33(1):58-70. doi: 10.1007/s00464-018-6268-z. Epub 2018 Jun 21.
5
Is Laparoscopic Gastrectomy More Advantageous for Elderly Patients Than for Young Patients with Resectable Advanced Gastric Cancer?腹腔镜胃切除术对可切除的老年进展期胃癌患者是否优于年轻患者?
World J Surg. 2020 Jul;44(7):2332-2339. doi: 10.1007/s00268-020-05486-2.
6
Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials.腹腔镜与开腹胃癌根治术治疗胃癌的近期和远期疗效:系统评价和随机对照试验的荟萃分析。
World J Surg Oncol. 2022 Dec 24;20(1):405. doi: 10.1186/s12957-022-02818-5.
7
Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study.腹腔镜手术与开放手术治疗临床I期胃癌的长期结果:LOC-1研究
Ann Surg. 2016 Aug;264(2):214-22. doi: 10.1097/SLA.0000000000001654.
8
Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study).腹腔镜与开放手术治疗临床 II/III 期胃癌的长期疗效:日本多中心队列研究(LOC-A 研究)。
Ann Surg. 2019 May;269(5):887-894. doi: 10.1097/SLA.0000000000002768.
9
Long-term survival outcomes of laparoscopic versus open gastrectomy for gastric cancer: a systematic review and meta-analysis.腹腔镜与开腹胃癌切除术的长期生存结局:一项系统评价与荟萃分析
Medicine (Baltimore). 2015 Jan;94(4):e454. doi: 10.1097/MD.0000000000000454.
10
Risk factors for recurrence of gastric cancer after curative laparoscopic gastrectomy.根治性腹腔镜胃切除术后胃癌复发的危险因素。
J Med Invest. 2017;64(1.2):79-84. doi: 10.2152/jmi.64.79.

引用本文的文献

1
Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives.胃癌的靶向治疗与免疫治疗:合理策略、新进展、挑战及未来展望
Mol Med. 2025 Feb 8;31(1):52. doi: 10.1186/s10020-025-01075-y.
2
Brain metastasis from gastric adenocarcinoma: A large comprehensive population-based cohort study on risk factors and prognosis.胃腺癌脑转移:一项基于大规模综合人群队列的危险因素及预后研究
Front Oncol. 2022 Oct 18;12:897681. doi: 10.3389/fonc.2022.897681. eCollection 2022.
3
Editorial: The use of chemotherapy in treating gastric cancers.

本文引用的文献

1
Outcomes of a Multicenter Training Program in Laparoscopic Pancreatoduodenectomy (LAELAPS-2).腹腔镜胰十二指肠切除术(LAELAPS-2)多中心培训项目的结果。
Ann Surg. 2019 Feb;269(2):344-350. doi: 10.1097/SLA.0000000000002563.
2
Short-Term Outcomes of Single-Incision Versus Conventional Laparoscopic Surgery for Colorectal Diseases: Meta-Analysis of Randomized and Prospective Evidence.单切口与传统腹腔镜手术治疗结直肠疾病的短期疗效比较:随机和前瞻性证据的荟萃分析。
J Gastrointest Surg. 2017 Nov;21(11):1931-1945. doi: 10.1007/s11605-017-3520-0. Epub 2017 Aug 3.
3
Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.
社论:化疗在胃癌治疗中的应用
Front Oncol. 2022 Jul 26;12:974023. doi: 10.3389/fonc.2022.974023. eCollection 2022.
观察性研究在为临床决策提供信息方面的未开发潜力:美国临床肿瘤学会研究声明。
J Clin Oncol. 2017 Jun 1;35(16):1845-1854. doi: 10.1200/JCO.2017.72.6414. Epub 2017 Mar 30.
4
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.胃癌临床实践指南(NCCN 肿瘤学版) 2016 年第 3 版
J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312. doi: 10.6004/jnccn.2016.0137.
5
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350.
6
Japanese gastric cancer treatment guidelines 2014 (ver. 4).《日本胃癌治疗指南2014(第4版)》
Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24.
7
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.腹腔镜与开腹 D2 远端胃癌根治术治疗进展期胃癌的疗效比较:一项随机对照临床试验。
J Clin Oncol. 2016 Apr 20;34(12):1350-7. doi: 10.1200/JCO.2015.63.7215. Epub 2016 Feb 22.
8
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.胃切除术加化疗与单纯化疗治疗有单一不可治愈因素的晚期胃癌(REGATTA):一项 3 期随机对照试验。
Lancet Oncol. 2016 Mar;17(3):309-318. doi: 10.1016/S1470-2045(15)00553-7. Epub 2016 Jan 26.
9
Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer.腹腔镜辅助与开腹全胃切除术治疗早期胃癌的疗效比较。
Br J Surg. 2015 Nov;102(12):1500-5. doi: 10.1002/bjs.9902. Epub 2015 Sep 23.
10
Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).与开放性远端胃癌切除术相比,腹腔镜远端胃癌切除术治疗Ⅰ期胃癌的发病率降低:一项多中心随机对照试验(KLASS-01)的短期结果
Ann Surg. 2016 Jan;263(1):28-35. doi: 10.1097/SLA.0000000000001346.